An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Mike Segar | Reuters A key monoclonal antibody used to treat peopl...
Tag: Antibody
Omicron BQ variants resistant to antibody treatments are becoming dominant in U.S.
Omicron subvariants resistant to key antibody treatments will soon make up a majority of new Covid infections in the U.S., according to the Centers for Disease Control and Prevention. Omicron subvaria...
EU Approves First Monoclonal Antibody To Prevent RSV In All Children As U.S. Cases Surge
Topline The European Commission on Friday approved the first monoclonal antibody to prevent respiratory syncytial virus (RSV) among all infants and newborns, amid a rise of cases of the highly contagi...
Twist Bioscience Revenue Growing From $2 To $200 Million As It Eyes The $186 Billion Antibody Market
Emily Leproust, Patrick Finn, Aaron Sato, and Tracey Mullen of Twist Bioscience. Twist Bioscience It’s another beautiful sunny day in San Francisco, and Twist Bioscience (NASDAQNDAQ : TWST) is making ...
Omicron subvariants resistant to key antibody treatments are increasing
Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1....
Antibodies From Covid Vaccines May Be Weaker Against Omicron, Study Finds
Topline Antibodies produced by Covid-19 vaccines and booster shots may be less effective at defending against the omicron variant than previous coronavirus strains, a study by researchers at Johns Hop...
Most Americans Have Had Covid, Antibody Tests Show
Topline More than half of all Americans—including around 75% of children—had evidence of a prior coronavirus infection in their bloodstream after the omicron variant raged nationwide, the Centers for ...
GSK, Vir Say Their Covid Antibody Treatment Can Neutralize Fast-Spreading Omicron Relative
Topline A Covid-19 antibody treatment developed by Vir Biotechnology and GlaxoSmithKline is still capable of neutralizing the infectious omicron subvariant, BA.2, Vir announced Thursday, offering earl...